Revvity (RVTY) | Financial Analysis & Statements
Revvity Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
772.1M
Gross Profit
421.7M
54.62%
Operating Income
111.7M
14.47%
Net Income
98.4M
12.74%
EPS (Diluted)
$0.87
Balance Sheet Metrics
Total Assets
12.2B
Total Liabilities
4.9B
Shareholders Equity
7.3B
Debt to Equity
0.68
Cash Flow Metrics
Operating Cash Flow
176.0M
Free Cash Flow
161.8M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Revvity Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.9B | 2.8B | 2.8B | 3.3B | 3.8B |
| Cost of Goods Sold | 1.3B | 1.2B | 1.2B | 1.3B | 1.4B |
| Gross Profit | 1.6B | 1.5B | 1.5B | 2.0B | 2.4B |
| Gross Margin % | 54.8% | 55.8% | 56.0% | 60.1% | 63.6% |
| Operating Expenses | |||||
| Research & Development | 215.8M | 196.8M | 216.6M | 221.6M | 200.3M |
| Selling, General & Administrative | 991.9M | 994.1M | 1.0B | 1.0B | 975.2M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B |
| Operating Income | 356.6M | 346.7M | 300.6M | 742.7M | 1.3B |
| Operating Margin % | 12.5% | 12.6% | 10.9% | 22.4% | 32.9% |
| Non-Operating Items | |||||
| Interest Income | 31.1M | 73.2M | 72.1M | 3.6M | 2.2M |
| Interest Expense | 92.2M | 96.3M | 98.8M | 104.0M | 102.1M |
| Other Non-Operating Income | -27.3M | -7.5M | -90.9M | 9.5M | 45.0M |
| Pre-tax Income | 268.3M | 316.1M | 183.0M | 651.8M | 1.2B |
| Income Tax | 28.4M | 33.1M | 3.5M | 139.2M | 314.1M |
| Effective Tax Rate % | 10.6% | 10.5% | 1.9% | 21.3% | 26.1% |
| Net Income | 241.2M | 270.4M | 693.1M | 569.2M | 943.2M |
| Net Margin % | 8.4% | 9.8% | 25.2% | 17.2% | 24.6% |
| Key Metrics | |||||
| EBITDA | 792.2M | 839.3M | 785.5M | 1.2B | 1.6B |
| EPS (Basic) | $2.07 | $2.24 | $5.62 | $4.59 | $7.39 |
| EPS (Diluted) | $2.07 | $2.20 | $5.55 | $4.58 | $7.39 |
| Basic Shares Outstanding | 116542000 | 120646000 | 123426000 | 126300000 | 126241000 |
| Diluted Shares Outstanding | 116542000 | 120646000 | 123426000 | 126300000 | 126241000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Revvity Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 919.9M | 1.2B | 913.2M | 454.4M | 603.3M |
| Short-term Investments | - | 0 | 689.9M | 0 | - |
| Accounts Receivable | 744.7M | 632.4M | 632.8M | 612.8M | 707.9M |
| Inventory | 379.5M | 367.6M | 428.1M | 405.5M | 425.9M |
| Other Current Assets | 195.7M | 186.2M | 337.1M | 122.3M | 148.3M |
| Total Current Assets | 2.2B | 2.3B | 3.0B | 3.3B | 2.4B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 165.4M | 167.7M | 155.1M | 188.4M | 164.0M |
| Goodwill | 15.6B | 15.6B | 16.1B | 16.3B | 17.1B |
| Intangible Assets | 2.3B | 2.6B | 3.0B | 3.4B | 3.8B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 323.5M | 288.4M | 343.0M | 311.1M | 1.5B |
| Total Non-Current Assets | 9.9B | 10.0B | 10.6B | 10.8B | 12.6B |
| Total Assets | 12.2B | 12.4B | 13.6B | 14.1B | 15.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 185.5M | 167.5M | 204.1M | 272.8M | 324.8M |
| Short-term Debt | 618.9M | 23.8M | 754.8M | 502.1M | 33.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | 272.9M | 205.6M |
| Total Current Liabilities | 1.3B | 653.1M | 1.5B | 1.5B | 1.2B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.8B | 3.3B | 3.3B | 4.1B | 5.1B |
| Deferred Tax Liabilities | - | - | - | 1.1B | 1.4B |
| Other Non-Current Liabilities | 807.5M | 770.5M | 930.9M | 1.1B | 1.4B |
| Total Non-Current Liabilities | 3.6B | 4.1B | 4.2B | 5.2B | 6.6B |
| Total Liabilities | 4.9B | 4.7B | 5.7B | 6.7B | 7.9B |
| Equity | |||||
| Common Stock | 112.3M | 120.6M | 123.4M | 126.3M | 126.2M |
| Retained Earnings | 6.1B | 5.8B | 5.6B | 5.0B | 4.4B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 7.3B | 7.7B | 7.9B | 7.4B | 7.1B |
| Key Metrics | |||||
| Total Debt | 3.4B | 3.3B | 4.1B | 4.6B | 5.2B |
| Working Capital | 908.5M | 1.7B | 1.6B | 1.7B | 1.2B |
Balance Sheet Composition
Revvity Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 239.9M | 283.1M | 179.5M | 512.7M | 889.4M |
| Depreciation & Amortization | 405.3M | 427.8M | 431.8M | 427.0M | 311.4M |
| Stock-Based Compensation | 22.8M | 37.8M | 41.4M | 51.5M | 29.7M |
| Working Capital Changes | -78.9M | 3.1M | -99.5M | -26.3M | 190.3M |
| Operating Cash Flow | 586.7M | 663.2M | 493.8M | 922.2M | 1.4B |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | 0 | 0 | -1.9M | 7.0M | -4.0B |
| Investment Purchases | -385.0K | -6.6M | -1.2B | -47.2M | -23.1M |
| Investment Sales | 304.0K | 712.5M | 550.0M | 0 | 0 |
| Investing Cash Flow | -81.0K | 705.9M | -679.8M | -31.3M | -4.0B |
| Financing Activities | |||||
| Share Repurchases | -820.8M | -369.6M | -388.9M | -80.6M | -73.1M |
| Dividends Paid | -32.8M | -34.5M | -35.0M | -35.3M | -32.4M |
| Debt Issuance | - | 0 | 0 | 240.0M | 5.0B |
| Debt Repayment | -521.0K | -723.1M | -523.8M | -797.9M | -1.9B |
| Financing Cash Flow | -860.4M | -1.1B | -951.5M | -661.8M | 2.9B |
| Free Cash Flow | 509.4M | 541.7M | 9.9M | 594.2M | 1.3B |
| Net Change in Cash | -273.8M | 233.2M | -1.1B | 229.1M | 363.1M |
Cash Flow Trend
Revvity Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
45.77
Forward P/E
15.70
Price to Book
1.46
Price to Sales
3.69
PEG Ratio
3.92
Profitability Ratios
Profit Margin
8.45%
Operating Margin
20.07%
Return on Equity
3.22%
Return on Assets
2.22%
Financial Health
Current Ratio
1.68
Debt to Equity
46.87
Beta
1.13
Per Share Data
EPS (TTM)
$2.06
Book Value per Share
$64.57
Revenue per Share
$24.51
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| RVTY | 9.7B | 45.77 | 1.46 | 3.22% | 8.45% | 46.87 |
| Thermo Fisher | 174.6B | 25.84 | 3.31 | 13.52% | 15.15% | 82.91 |
| Danaher | 126.4B | 34.61 | 2.40 | 7.08% | 14.89% | 37.17 |
| Icon plc | 9.0B | 15.52 | 0.94 | 6.27% | 7.40% | 38.26 |
| Charles River | 8.3B | 681.33 | 2.61 | -4.23% | -3.60% | 81.95 |
| Qiagen N.V | 7.9B | 18.76 | 2.09 | 11.57% | 20.33% | 48.56 |
Financial data is updated regularly. All figures are in the company's reporting currency.





